CD8A and COVID-19: Among the co-inhibitory receptors, LAG3, CTLA4, and HAVCR2 were enriched in CD8+ T cells from COVID-19 patients that eventually succumbed to the disease, but PDCD1 and TIGIT were enriched in CD8+ T cells from COVID-19 patients that eventually recovered and discharged (76).